Impact of postoperative radiotherapy and chemoradiotherapy on survival outcomes in oral squamous cell carcinoma patients with pN1 neck disease
Struckmeier A, Smeets R, Petersen C, Betz C, Wilczak W, Gosau M
CLIN ORAL INVEST. 2026;30(1):47.

Immunotherapeutic strategies beyond the PD-1/PD-L1 pathway in head and neck squamous cell carcinoma - A scoping review on current developments in agents targeting TIM-3, TIGIT, LAG-3, and VISTA
Struckmeier A, Gosau M, Smeets R
ORAL ONCOL. 2025;161:.

Radiation-induced sarcomas of the craniofacial region: A systematic review
Struckmeier A, Gosau M, Smeets R
ORAL ONCOL. 2025;164:107282.

Sentinel lymph node biopsy in early-stage oral squamous cell carcinoma: clinical outcomes and optimal lymph node removal thresholds
Struckmeier A, König D, Klutmann S, Smeets R
ORAL ONCOL. 2025;168:.

Diagnostic accuracy of contrast-enhanced computed tomography in assessing bone invasion in patients with oral squamous cell carcinoma
Struckmeier A, Buchbender M, Agaimy A, Kesting M
CLIN ORAL INVEST. 2024;28(6):314.

Prevalence and implications of bilateral and solely contralateral lymph node metastases in oral squamous cell carcinoma
Struckmeier A, Buchbender M, Agaimy A, Kesting M
CLIN ORAL INVEST. 2024;28(5):267.

Improved recurrence rates and progression-free survival in primarily surgically treated oral squamous cell carcinoma - results from a German tertiary medical center
Struckmeier A, Buchbender M, Lutz R, Kesting M
CLIN ORAL INVEST. 2024;28(5):262.

Cutaneous squamous cell carcinoma in solid organ transplant recipients: Current therapeutic and screening strategies
Struckmeier A, Gosau M, Smeets R
Transplant Rev (Orlando). 2024;38(4):.

Letzte Aktualisierung aus dem FIS: 08.06.2026 - 06:47 Uhr